| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.ECL.2004.03.001 |
| P698 | PubMed publication ID | 15158519 |
| P2093 | author name string | Scott M Grundy | |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 267-82, table of contents | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Endocrinology and Metabolism Clinics of North America | Q15763298 |
| P1476 | title | What is the contribution of obesity to the metabolic syndrome? | |
| P478 | volume | 33 |
| Q34498578 | Adiposopathy is a more rational treatment target for metabolic disease than obesity alone |
| Q36087475 | Analysis of Cardiovascular Risk Factors in Adults with Congenital Heart Disease. |
| Q83012491 | Association of metabolic syndrome with reduced central serotonergic activity |
| Q27887268 | Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: Role of sarcolemmal substrate transporters |
| Q40362288 | Depression, obesity, and metabolic syndrome: prevalence and risks of comorbidity in a population-based representative sample of Mexican Americans |
| Q35897949 | Direct effects of leptin and adiponectin on peripheral reproductive tissues: a critical review |
| Q90134967 | Effect of Cucumis sativus on Dysfunctional 3T3-L1 Adipocytes |
| Q51938302 | Epidemiological evidence for the non-random clustering of the components of the metabolic syndrome: multicentre study of the Mediterranean Group for the Study of Diabetes. |
| Q64229793 | Impact of Nutritional Intake on Function in People with Mild-to-Moderate Multiple Sclerosis |
| Q92708651 | Incidence and effect of insulin resistance on progression of atherosclerosis in rheumatoid arthritis patients of long disease duration |
| Q24532776 | Insulin and insulin resistance. |
| Q37311415 | Mediators of sympathetic activation in metabolic syndrome obesity |
| Q36039087 | Metabolic syndrome and other factors associated with increased risk of diabetes |
| Q38204543 | Metabolic syndrome: a sympathetic disease? |
| Q35814941 | Neuronal and Endothelial Nitric Oxide Synthases in the Paraventricular Nucleus Modulate Sympathetic Overdrive in Insulin-Resistant Rats |
| Q37323375 | Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity. |
| Q61813117 | Oxidative Stress and Nutraceuticals in the Modulation of the Immune Function: Current Knowledge in Animals of Veterinary Interest |
| Q37296393 | Potential role of interleukin-18 in patients with rheumatoid arthritis-associated carotid intima-media thickness but not insulin resistance |
| Q51612503 | Strain/strain rate imaging of impaired left atrial function in patients with metabolic syndrome. |
| Q38061158 | The effects of whey protein on cardiometabolic risk factors |
| Q33886816 | The genetics of obesity and the metabolic syndrome |
| Q34018184 | The health implications of sucrose, high-fructose corn syrup, and fructose: what do we really know? |
| Q36174974 | The inflammation highway: metabolism accelerates inflammatory traffic in obesity |
| Q36394371 | The metabolic syndrome, hyperlipidemia, and insulin resistance |
| Q34018084 | The small molecule indirubin-3'-oxime activates Wnt/β-catenin signaling and inhibits adipocyte differentiation and obesity |
| Q34054063 | Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine. |
Search more.